MétaCan
Menu
Back to cohort

P-004 Anti-TNF (Infliximab) Plus mTOR Inhibitor (sirolimus) for Induction of Remission in Severe Steroid—Refractory Ulcerative Colitis

2014· article· en· W2312615589 on OpenAlexaboutno aff
Lopez Acosta Maria, Ovilla Martinez Roberto, Morales Gutierrez Oscar, Cabrera Garcia Alvaro, Barrera Carmona Claudia

Bibliographic record

VenueInflammatory Bowel Diseases · 2014
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicInflammatory Bowel Disease
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineSirolimusUlcerative colitisInfliximabGastroenterologyMesalazineInternal medicineProinflammatory cytokineInflammatory bowel diseaseImmunologyTumor necrosis factor alphaInflammationDisease

Abstract

fetched live from OpenAlex

Ulcerative colitis (UC) is an inflammatory and autoimmune disease, characterized by increased cell proliferation, activation of T cells, production of proinflammatory cytokines and leukocyte infiltration. Some compounds have shown antiproliferative therapeutic effect in UC murine models. Sirolimus inhibits mTOR (mammalian target of rapamycin) which is a serine / threonine protein kinase that regulates cell growth, cell proliferation, cell motility, cell survival, protein synthesis, and transcription. Inhibition of mTOR has shown a significant decrease in the Disease Activity Index (UC-DAI), leukocyte infiltration and damage of the crypts in the colonic mucosa. However, there is no evidence of cooperative effect to induce remission when added sirolimus to an anti-TNF (chimeric anti-tumor necrosis factor-α antibody with a potent anti-inflammatory effect) in patients with severe steroid-refractory UC. A 30 year old man, with a 12 year history of severe UC (Truelove & Witts severity index) with an average of 10 watery stools a day accompanied by blood. Initially hemoglobin (Hb) was 10 g/dL and erythrocyte sedimentation rate (ESR) 32 mm/hr. Colonoscopy showed complete left sided involvement, marked erythema, friability, erosions, ulcerations and spontaneous bleeding (Mayo Clinic index score 12 points, Montreal Classification S3 E2). The patient has been treated with mesalazine and prednisone achieving short partial remissions (as the best response reached), during the first 8 years of evolution of the disease he has suffered frequent periods of exacerbation and a toxic megacolon event. The past 6 months have dramatically increased the severity and the number of evacuations (20 liquid-stools a day and sometimes only blood-stools), abdominal pain but with no satisfactory response to steroids. He had also severe iron-deficiency anemia (Hb 4.5 g/dL, Mean Corpuscular Volume 71 fl and ESR 40 mm/hr) requiring erythrocyte transfusions and intravenous iron. Infliximab 5 mg/kg was initiated once a week showing partial improvement of symptoms, therefore after 2 weeks, Sirolimus 2 mg/day was added, showing extraordinary improvement of symptoms, with reduction in the number of stools (1-2 daily) no bleeding or pain, Hb 14 g/dL and ESR 18 mm/hr, fulfilling clinical criteria for complete remission. He completed a total of 8 cycles of Anti TNF and continued sirolimus as maintenance, keeping an excellent evolution. Case report described above. Case report described above. Comprehensive treatment of patients with severe UC, including intravenous iron, supportive measures and this case shows that the addition of a mTOR inhibitor to anti-TNF could be a suitable combination for the induction of a complete remission in UC. It will require to be tested in a large group of patients with severe steroid-refractory disease.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Other · Consensus signal: none
Teacher disagreement score0.002
Threshold uncertainty score0.005

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.008
GPT teacher head0.240
Teacher spread0.232 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2014
Admission routes1
Has abstractyes

Explore more

Same venueInflammatory Bowel DiseasesSame topicInflammatory Bowel DiseaseFrench-language works237,207